Identification of the estrogen sensitive marker in human endometrial carcinoma RL95-2 cells

Mol Cell Endocrinol. 1994 May;101(1-2):167-71. doi: 10.1016/0303-7207(94)90231-3.

Abstract

Estrogen exerts a variety of biological effects on human reproductive tissues. However, little is understood about the estrogenic effect on human endometrial cells in vitro. This study was designed to investigate estrogen action on c-myc and c-fos oncogenes and lactoferrin gene expression in human endometrial carcinoma RL95-2 cells. The results indicate that estrogen can induce c-myc oncogene expression in 4 h. Neither c-fos nor the lactoferrin messenger was detectable, nor could they be induced by estrogen. Transfection with human estrogen receptor expression vector to the RL95-2 cells does not restore the estrogen responsiveness. In addition to estrogen, epidermal growth factor (EGF) and tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) can also induce c-myc expression with no effect on c-fos or lactoferrin expression. Our data suggest that the c-myc oncogene in human endometrial carcinoma RL95-2 cells is the sensitive target gene for steroid hormone and growth factor action.

MeSH terms

  • Carcinoma / genetics*
  • Carcinoma / metabolism*
  • Endometrial Neoplasms / genetics*
  • Endometrial Neoplasms / metabolism*
  • Estrogens / pharmacology*
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Genes, fos
  • Genes, myc
  • Humans
  • Lactoferrin / biosynthesis*
  • Proto-Oncogene Proteins c-fos / biosynthesis*
  • Proto-Oncogene Proteins c-myc / biosynthesis*
  • RNA, Messenger / analysis
  • Signal Transduction / drug effects
  • Tumor Cells, Cultured

Substances

  • Estrogens
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-myc
  • RNA, Messenger
  • Lactoferrin